期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
多巴丝肼、普拉克索联合治疗帕金森病的效果及对PARK2、CKMT1A、Netrin-1的影响
1
作者 嵇继宇 王莉 +2 位作者 田小军 王玉梅 苏洲 《成都医学院学报》 CAS 2024年第1期66-69,74,共5页
目的探究多巴丝肼、普拉克索联合治疗帕金森病(PD)的效果及对人帕金森病蛋白2(PARK2)、线粒体肌酸激酶1A(CKMT1A)及神经轴突导向因子1(Netrin-1)的影响。方法选择2021年7月至2023年6月于新乡医学院第一附属医院治疗的PD患者108例为研究... 目的探究多巴丝肼、普拉克索联合治疗帕金森病(PD)的效果及对人帕金森病蛋白2(PARK2)、线粒体肌酸激酶1A(CKMT1A)及神经轴突导向因子1(Netrin-1)的影响。方法选择2021年7月至2023年6月于新乡医学院第一附属医院治疗的PD患者108例为研究对象,依据随机数字表法分为试验组和对照组,每组54例。对照组行多巴丝肼治疗,试验组行多巴丝肼、普拉克索联合治疗。观察两组治疗前后PD严重程度,认知功能水平,睡眠障碍情况,血清PARK2、CKMT1A、Netrin-1水平和不良反应。结果治疗后,试验组统一PD评定量表(UPDRS)各分项得分及总分、匹兹堡睡眠质量指数量表(PSQI)评分均低于对照组(P<0.05),简易智力状态检查量表(MMSE)评分高于对照组(P<0.05)。试验组血清PARK2、Netrin-1水平均高于对照组(P<0.05),血清CKMT1A水平低于对照组(P<0.05)。试验组总有效率大于对照组(P<0.05)。两组不良反应发生率差异无统计学意义(P>0.05)。结论多巴丝肼、普拉克索联合治疗PD可缓解患者症状,提高其认知功能及睡眠质量,改善血清PARK2、CKMT1A、Netrin-1水平。 展开更多
关键词 多巴丝肼 普拉克索 帕金森病 人帕金森病蛋白2 线粒体肌酸激酶 神经轴突导向因子1
下载PDF
Neutrophil-derived PAD4 induces citrullination of CKMT1 exacerbates mucosal inflammation in inflammatory bowel disease
2
作者 Shuling Wang Yihang Song +11 位作者 Zhijie Wang Xin Chang Haicong Wu Ziwei Yan Jiayi Wu Zixuan He Le Kang Wenjun Hu Tian Xia Zhaoshen Li Xingxing Ren Yu Bai 《Cellular & Molecular Immunology》 SCIE CAS 2024年第6期620-633,共14页
Peptidyl arginine deiminase 4(PAD4)plays a pivotal role in infection and inflammatory diseases by facilitating the formation of neutrophil extracellular traps(NETs).However,the substrates of PAD4 and its exact role in... Peptidyl arginine deiminase 4(PAD4)plays a pivotal role in infection and inflammatory diseases by facilitating the formation of neutrophil extracellular traps(NETs).However,the substrates of PAD4 and its exact role in inflammatory bowel disease(IBD)remain unclear.In this study,we employed single-cell RNA sequencing(scRNA-seq)and substrate citrullination mapping to decipher the role of PAD4 in intestinal inflammation associated with IBD.Our results demonstrated that PAD4 deficiency alleviated colonic inflammation and restored intestinal barrier function in a dextran sulfate sodium(DSS)-induced colitis mouse model.scRNA-seq analysis revealed significant alterations in intestinal cell populations,with reduced neutrophil numbers and changes in epithelial subsets upon PAD4 deletion.Gene expression analysis highlighted pathways related to inflammation and epithelial cell function.Furthermore,we found that neutrophil-derived extracellular vesicles(EVs)carrying PAD4 were secreted into intestinal epithelial cells(IECs).Within IECs,PAD4 citrullinates mitochondrial creatine kinase 1(CKMT1)at the R242 site,leading to reduced CKMT1 protein stability via the autophagy pathway.This action compromises mitochondrial homeostasis,impairs intestinal barrier integrity,and induces IECs apoptosis.IEC-specific depletion of CKMT1 exacerbated intestinal inflammation and apoptosis in mice with colitis.Clinical analysis of IBD patients revealed elevated levels of PAD4,increased CKMT1 citrullination,and decreased CKMT1 expression.In summary,our findings highlight the crucial role of PAD4 in IBD,where it modulates IECs plasticity via CKMT1 citrullination,suggesting that PAD4 may be a potential therapeutic target for IBD. 展开更多
关键词 Peptidyl-arginine deiminase-4 Citrullination mitochondrial creatine kinase 1 Intestinal epithelial cells Inflammatory bowel disease
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部